104 related articles for article (PubMed ID: 20105250)
1. Childhood minimally invasive follicular carcinoma: clinical features and immunohistochemistry analysis.
Zou CC; Zhao ZY; Liang L
J Paediatr Child Health; 2010 Apr; 46(4):166-70. PubMed ID: 20105250
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas.
Huang CC; Hsueh C; Liu FH; Chao TC; Lin JD
Surg Oncol; 2011 Mar; 20(1):1-6. PubMed ID: 19596568
[TBL] [Abstract][Full Text] [Related]
3. Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients.
Goffredo P; Cheung K; Roman SA; Sosa JA
Ann Surg Oncol; 2013 Mar; 20(3):767-72. PubMed ID: 23111705
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
Abd-El Raouf SM; Ibrahim TR
Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
[TBL] [Abstract][Full Text] [Related]
5. [Coincidence of unifocal thyroid autonomy and follicular carcinoma. Case report].
Einert A; Blattmann H; Reinhardt M; Moser E
Radiologe; 1995 Aug; 35(8):531-4. PubMed ID: 7568800
[TBL] [Abstract][Full Text] [Related]
6. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.
Liu YY; Morreau H; Kievit J; Romijn JA; Carrasco N; Smit JW
Eur J Endocrinol; 2008 Mar; 158(3):375-84. PubMed ID: 18299472
[TBL] [Abstract][Full Text] [Related]
7. Management of thyroid cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969-1995.
Martins RG; Caplan RH; Lambert PJ; Rooney B; Kisken WA
J Am Coll Surg; 1997 Oct; 185(4):388-97. PubMed ID: 9328388
[TBL] [Abstract][Full Text] [Related]
8. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and therapy of thyroid carcinoma].
Hölting T; Herfarth C
Dtsch Med Wochenschr; 1997 Sep; 122(36):1077-80. PubMed ID: 9333531
[No Abstract] [Full Text] [Related]
10. Histopathology, Immunohistochemistry and Molecular Biology of Follicular Epithelium-Derived Pediatric Thyroid Carcinomas.
Collini P; Barisella M; Greco A
Curr Pediatr Rev; 2016; 12(4):272-279. PubMed ID: 27804857
[TBL] [Abstract][Full Text] [Related]
11. Metastatic follicular thyroid carcinoma: a case report.
Sathasivam H; Loh YM; Saw CL; Khalid N
Gerodontology; 2017 Jun; 34(2):276-279. PubMed ID: 27384017
[TBL] [Abstract][Full Text] [Related]
12. Postoperative spindle cell nodule after thyroidectomy: a case mimicking recurrence with anaplastic transformation of thyroid cancer.
Kim SW; Oh YL; Choi JY; Lee JI; Chung JH; Kim JS
Head Neck; 2013 Jan; 35(1):E13-7. PubMed ID: 22106010
[TBL] [Abstract][Full Text] [Related]
13. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
[TBL] [Abstract][Full Text] [Related]
14. Mixed follicular-medullary thyroid carcinoma: a case report.
Luboshitzky R; Dharan M
Diagn Cytopathol; 2004 Feb; 30(2):122-4. PubMed ID: 14755766
[TBL] [Abstract][Full Text] [Related]
15. Thyroid follicular carcinoma-like tumor of kidney: a case report with morphologic, immunohistochemical, and genetic analysis.
Jung SJ; Chung JI; Park SH; Ayala AG; Ro JY
Am J Surg Pathol; 2006 Mar; 30(3):411-5. PubMed ID: 16538064
[TBL] [Abstract][Full Text] [Related]
16. Thyroid follicular carcinoma: sonographic features of 50 cases.
Sillery JC; Reading CC; Charboneau JW; Henrichsen TL; Hay ID; Mandrekar JN
AJR Am J Roentgenol; 2010 Jan; 194(1):44-54. PubMed ID: 20028904
[TBL] [Abstract][Full Text] [Related]
17. Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid.
Cho Mar K; Eimoto T; Nagaya S; Tateyama H
Histopathology; 2006 Jun; 48(7):801-7. PubMed ID: 16722928
[TBL] [Abstract][Full Text] [Related]
18. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
19. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
20. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
